Skip to main content
Premium Trial:

Request an Annual Quote

GeneThera Acquires Majority Stake in Applied Genetics

NEW YORK (GenomeWeb News) – GeneThera today announced it has acquired a majority ownership of molecular diagnostic firm Applied Genetics for an undisclosed amount.

GeneThera said the deal is part of a broader strategy to begin revenue generation at Applied Genetics, which is based in Monterrey, Mexico and focuses on commercializing tests for Johne's disease in Mexico.

GeneThera is a molecular biotech firm based in Westminster, Colo. Its diagnostic solution, it said, is based on a genetic expression assay called GES and Johne's disease management system Herdcheck, which is "designed to function on a highly automated Fluorogenic PCR platform."

GES and Herdcheck are designed for a variety of diseases.

Johne's disease affects dairy cows, sheep, and goats and is caused by Mycobacterium Paratuberculosis sub. Avium (MAP). MAP has been shown in studies to be a cause of Crohn's disease in humans.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.